ARCHIVES

Appeals Court Overturns FDA Approval Of Generic Paclitaxel, A Setback For Ivax.

This article is from The Cancer Letter archive.

Vol. 27 No. 41 | November 9, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: MB Ends Apportionment Carlo Croce To Head Fels Institute, Replacing Peter Magee Sept. 1

March 4, 1988

Anti-Nausea Drug Successful In Phase III Trial in Highly Emetogenic Chemotherapy

May 30, 2014

HHS Appoints 13 To Genetics Committee

January 17, 2003

PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III

November 28, 2014

Lung Cancer Prevention Diet Study Concept Tabled By DCPC Board

February 8, 1985

NCAB Subcommittee Likes Organ Site Program, Except Smoking-Health

April 30, 1976